ICM
JLL icon

Invenomic Capital Management’s Jones Lang LaSalle JLL Stock Holding History

Invenomic Capital Management’s Portfolio JLL Stock Details JLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-384
Closed -$39K – 170
2020
Q1 		$39K Sell
384
-11,564
-97% -$1.74M 0.03% 149
2019
Q4 		$2.08M Buy
+11,948
New +$1.88M 0.84% 52

Other funds holding JLL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Invenomic Capital Management's JLL Position: Q2 2020 in Review

Invenomic Capital Management sold out of Jones Lang LaSalle (JLL) in Q2 2020, closing a stake of 384 shares — an estimated $39K sold.

Invenomic Capital Management first reported a position in JLL in Q4 2019 and held it in 2 quarters. The position peaked at $2.08M in Q4 2019. 376 funds tracked by Wall St. Rank hold JLL as of Q2 2020.

  • Invenomic Capital Management reported no remaining Jones Lang LaSalle position as of Q2 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 384 Jones Lang LaSalle shares in Q2 2020, an estimated $39K.
  • Invenomic Capital Management first reported a position in Jones Lang LaSalle in Q4 2019 and held it in 2 quarters.
  • Invenomic Capital Management's Jones Lang LaSalle position peaked at $2.08M in Q4 2019.
  • 376 funds tracked by Wall St. Rank held Jones Lang LaSalle as of Q2 2020.

Based on Invenomic Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.